Bevezetés: A 2-es típusú cukorbetegség ma már „világjárvány”, megelőzése csak a „praediabetes” idején eredményes, ezért olyan szűrővizsgálatokra van szükség, amelyek a cukorbetegség várományosait időben felfedik. Célkitűzés: A szerzők célul tűzték ki egészséges, negatív családi anamnézisű (genetikailag nem diabeteses) és elsőfokú cukorbeteg rokonokkal rendelkező (genetikailag diabeteses), normális szénhidrát-toleranciájú és inzulinérzékenységű nőkben a diagnosztikai értékű anyagcsere-eltérések feltárását. Módszer: A klemp vizsgálatok során normális inzulinérzékenységű, genetikailag nem diabeteses (n = 26) és genetikailag diabeteses (n = 18) önkéntesek adatait elemezték. Eredmények: Genetikailag diabeteses, egészséges nőkben az orális cukorterhelés 120. percében magasabb glükóz- és inzulinkoncentrációt, valamint nagyobb magas denzitású és kisebb alacsony denzitású lipidszintet találtak a genetikailag nem diabeteses egészséges nőkben mért értékekhez képest. Következtetések: Az eredmények szerint genetikailag diabeteses, egészséges nőkben a kialakuló inzulinrezisztenciát megelőzi a hepaticus inzulinrezisztencia és a zsíranyagcsere zavara. A szerzők nem kaptak választ arra a kérdésre, hogy a cukorbetegséghez és az elhízáshoz vezető energiafelesleg miért okoz genetikailag diabeteses nőkben korán zsíranyagcsere-zavart és hyperinsulinaemiát, továbbá arra sem, hogy az elhízás miért nem társul mindig inzulinrezisztenciával. Orv. Hetil., 2013, 154, 1747–1753.
Shaw, J. E., Sicree, R. A., Zimmet, P. Z.: Global estimates of the prevalance of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract., 2010, 87, 4–14.
Zimmet P. Z. , 'Global estimates of the prevalance of diabetes for 2010 and 2030 ' (2010 ) 87 Diabetes Res. Clin. Pract. : 4 -14 .
Fazeli Farsani, S., van der Aa, M. P., van der Vorst, M. M. J., et al.: Global trends in the incidence and prevalance of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches. Diabetologia, 2013, 56, 1471–1488.
Vorst M. M. J. , 'Global trends in the incidence and prevalance of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches ' (2013 ) 56 Diabetologia : 1471 -1488 .
Liu, L. L., Yi, J. P., Beyer, J., et al.: Type 1 and type 2 diabetes in Asian and Pacific Islander U.S. youth: the SEARCH for Diabetes in Youth Study. Diabetes Care, 2009, 32 (Suppl. 2), S133–S140.
Beyer J. , 'Type 1 and type 2 diabetes in Asian and Pacific Islander U.S. youth: the SEARCH for Diabetes in Youth Study ' (2009 ) 32 Diabetes Care : S133 -S140 .
Mayer-Davis, E. J., Beyer, J., Bell, R. A., et al.: Diabetes in African American youth: prevalance, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care, 2009, 32 (Suppl. 2), S112–S122.
Bell R. A. , 'Diabetes in African American youth: prevalance, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study ' (2009 ) 32 Diabetes Care : S112 -S122 .
Hu, F. B., Manson, J. E., Stampfer, M. J., et al.: Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N. Engl. J. Med., 2001, 345, 790–797.
Stampfer M. J. , 'Diet, lifestyle, and the risk of type 2 diabetes mellitus in women ' (2001 ) 345 N. Engl. J. Med. : 790 -797 .
Lindström, J., Louheranta, A., Mannelin, M., et al: The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care, 2003, 26, 3230–3236.
Mannelin M. , 'The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity ' (2003 ) 26 Diabetes Care : 3230 -3236 .
Chiasson, J. L., Josse, R. G., Gomis, R., et al.: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet, 2002, 359, 2072–2077.
Gomis R. , 'Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial ' (2002 ) 359 Lancet : 2072 -2077 .
The DREAM Trial Investigators, Gerstein, H. C., Yusuf, S., Bosch, J., et al.: Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet, 2006, 368, 1096–1105.
Bosch J. , 'Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial ' (2006 ) 368 Lancet : 1096 -1105 .
Perreault, L., Pan, Q., Mather, K. J., et al.: Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet, 2012, 379, 2243–2251.
Mather K. J. , 'Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study ' (2012 ) 379 Lancet : 2243 -2251 .
Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med., 2002, 346, 393–403.
'Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin ' (2002 ) 346 N. Engl. J. Med. : 393 -403 .
Qi, Q., Hu, F. B.: Genetics of type 2 diabetes in European populations. J. Diabetes, 2012, 4, 203–212.
Hu F. B. , 'Genetics of type 2 diabetes in European populations ' (2012 ) 4 J. Diabetes : 203 -212 .
Jermendy, G., Horváth, T., Littvay, L., et al.: Effect of genetic and environmental influences on cardiometabolic risk factors: a twin study. Cardiovasc. Diabetol., 2011, 10, 96. doi: 10.1186/1475-2840-10-96
Littvay L. , 'Effect of genetic and environmental influences on cardiometabolic risk factors: a twin study ' (2011 ) 10 Cardiovasc. Diabetol. : 96 -.
Follow-up report on the diagnosis of diabetes mellitus. The expert committee on the diagnosis and classification of diabetes mellitus. Position statment. Diabetes Care, 2003, 26, 3160–3167.
DeFronzo, R. A., Abdul-Ghani, M.: Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am. J. Cardiol., 2011, 108 (Suppl. 3), 3B–24B.
Abdul-Ghani M. , 'Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose ' (2011 ) 108 Am. J. Cardiol. : 3B -24B .
Ikkos, D., Luft, R.: On the intravenous glucose tolerance test. Acta Endocrinol. (Copenh.), 1957, 25, 312–334.
Luft R. , 'On the intravenous glucose tolerance test ' (1957 ) 25 Acta Endocrinol. (Copenh.) : 312 -334 .
Wareham, N. J., Phillips, D. I., Byrne, C. D., et al.: The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet. Med., 1995, 12, 931.
Byrne C. D. , 'The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion ' (1995 ) 12 Diabet. Med. : 931 -.
A Programming Environment for Data Analysis and Graphics Version 2.15.0 ( http://cran.hu.r.-project.org )
Liaw, A., Wiener, M.: Classification and regression by random forest. R. News, 2000, 2, 18–22.
Wiener M. , 'Classification and regression by random forest ' (2000 ) 2 R. News : 18 -22 .
Kahn, S. E.: The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia, 2003, 46, 3–19.
Kahn S. E. , 'The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes ' (2003 ) 46 Diabetologia : 3 -19 .
Groop, L., Forsblom, C., Lehtovirta, M., et al.: Metabolic consequences of family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes, 1996, 45, 1585–1593.
Lehtovirta M. , 'Metabolic consequences of family history of NIDDM (the Botnia study): evidence for sex-specific parental effects ' (1996 ) 45 Diabetes : 1585 -1593 .
Yki-Järvinen, H., Westerbacka, J.: The fatty liver and insulin resistance. Curr. Mol. Med., 2005, 5, 287–295.
Westerbacka J. , 'The fatty liver and insulin resistance ' (2005 ) 5 Curr. Mol. Med. : 287 -295 .
Turner, N., Kowalski, G. M., Leslie, S. J., et al.: Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia, 2013, 56, 1638–1648.
Leslie S. J. , 'Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding ' (2013 ) 56 Diabetologia : 1638 -1648 .
Chan, D. C., Watts, G. F., Ng, T. W., et al.: Measurement of liver fat by magnetic resonance imaging: relationships with body fat distribution, insulin sensitivity and plasma lipids in healthy men. Diabetes Obes. Metab., 2006, 8, 698–702.
Ng T. W. , 'Measurement of liver fat by magnetic resonance imaging: relationships with body fat distribution, insulin sensitivity and plasma lipids in healthy men ' (2006 ) 8 Diabetes Obes. Metab. : 698 -702 .
Elgzyri, T., Parikh, H., Zhou, Y., et al.: First-degree relatives of type 2 diabetic patients have reduced expression of genes involved in fatty acid metabolism in skeletal muscle. J. Clin. Endocrinol. Metab., 2012, 97, E1332–E1337.
Zhou Y. , 'First-degree relatives of type 2 diabetic patients have reduced expression of genes involved in fatty acid metabolism in skeletal muscle ' (2012 ) 97 J. Clin. Endocrinol. Metab. : E1332 -E1337 .
Fernández-Sánchez, A., Madrigal-Santillán, E., Bautista, M., et al.: Inflammation, oxidative stress and obesity. Int. J. Mol. Sci., 2011, 12, 3117–3132.
Bautista M. , 'Inflammation, oxidative stress and obesity ' (2011 ) 12 Int. J. Mol. Sci. : 3117 -3132 .
Kehlenbrink, S., Koppaka, S., Martin, M., et al.: Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glucogenolysis. Diabeteologia, 2012, 55, 3021–3028.
Martin M. , 'Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glucogenolysis ' (2012 ) 55 Diabeteologia : 3021 -3028 .
Gerber, P. A., Berneis, K.: Regulation of low-density lipoprotein subfractions by carbohydrates. Curr. Opin. Clin. Nutr. Metab. Care, 2012, 15, 381–385.
Berneis K. , 'Regulation of low-density lipoprotein subfractions by carbohydrates ' (2012 ) 15 Curr. Opin. Clin. Nutr. Metab. Care : 381 -385 .
Bloomgarden, Z. T.: Inflammation and insulin resistance. Diabetes Care, 2003, 26, 1922–1926.
Bloomgarden Z. T. , 'Inflammation and insulin resistance ' (2003 ) 26 Diabetes Care : 1922 -1926 .
Donath, M. Y., Shoelson, S. E.: Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol., 2011, 11, 98–107.
Shoelson S. E. , 'Type 2 diabetes as an inflammatory disease ' (2011 ) 11 Nat. Rev. Immunol. : 98 -107 .
Buday, B., Kulcsár, E., Literáti-Nagy, B., et al.: The role of osteocalcin in the connection of bone and glucose metabolism in humans. [Az osteocalcin helye a humán cukor- és csontanyagcsere kapcsolatában.] Orv. Hetil., 2008, 149, 2453–2461. [Hungarian]
Literáti-Nagy B. , 'The role of osteocalcin in the connection of bone and glucose metabolism in humans. [Az osteocalcin helye a humán cukor- és csontanyagcsere kapcsolatában.] ' (2008 ) 149 Orv. Hetil. : 2453 -2461 .
Ouchi, N., Parker, J. L., Lugus, J. J., et al.: Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol., 2011, 11, 85–97.
Lugus J. J. , 'Adipokines in inflammation and metabolic disease ' (2011 ) 11 Nat. Rev. Immunol. : 85 -97 .